NASDAQ:NCNA - NuCana plc
$9.58
 $0.06
+0.63%
4:00PM EDT
2019-07-15
NuCana PLC, incorporated on January 28, 1997, is a clinical-stage biopharmaceutical company. The Company is focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The Company utilizes its ProTide technology to develop medicines to overcome cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Its pipeline of products includes Acelarin, NUC-3373 and NUC-7738.AcelarinAcelarin is a nucleotide analog and is a ProTide transformation of gemcitabine for the treatment of cancer. The Company is evaluating Acelarin in four clinical trials across several solid tumor indications, including ovarian cancer, biliary cancer and pancreatic cancer.NUC-3373NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil for the treatment of a wide range of cancers. NUC-3373 is currently in a Phase I trial for the potential treatment of a wide range of solid tumor cancers.NUC-7738NUC-7738 is a ProTide transformation of cordycepin, a novel nucleoside analog. The Company is evaluating NUC-7738 in preclinical studies. It is developing NUC-7738 for the treatment of solid tumors and Hematology.. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  NCNA     avg for
industry  
  avg for
sector  
42 stocks weight:  13. 07   114. 77   204. 78  
42 stocks rank:  3. 56 K 1. 44 K 810. 33  
# analyst opinions:  3. 00   13. 59   13. 86  

quick ratio:  14. 43   5. 48   1. 89  
current ratio:  14. 96   5. 85   2. 40  

target price low:  25. 46   82. 72   115. 11  
target price avg:  26. 25   104. 42   138. 02  
target price high:  27. 84   130. 64   159. 47  
1-yr high:  26. 86   110. 27   142. 72  
last close:  9. 52   85. 12   126. 54  
50-day avg:  12. 41   86. 06   122. 35  
200-day avg:  15. 07   88. 76   121. 75  
1-yr low:  9. 52   69. 26   100. 63  
volume:  15. 21 K 3. 51 M 5. 53 M
50-day avg volume:  29. 33 K 3. 21 M 4. 22 M
200-day avg volume:  58. 30 K 3. 04 M 4. 75 M

1-day return:  -2. 36 % -0. 30 % -1. 01 %
this week return:  -2. 76 % -2. 16 % -1. 35 %
12-wk return:  -29. 74 % 3. 34 % 8. 69 %
52-wk return:  -58. 92 % -1. 76 % 12. 22 %

enterprise value (EV):  327. 20 M 46. 50 B 123. 99 B
market cap:  299. 62 M 40. 77 B 109. 11 B
debt/equity:  0. 69   57. 36   120. 25  

shares outstanding:  32. 24 M 551. 08 M 1. 24 B
shares:  12. 86 M 559. 41 M 1. 22 B
shares short:  2. 28 M 11. 15 M 11. 94 M
shares short prior month:  2. 40 M 9. 31 M 11. 96 M
short ratio:  63. 36   5. 72   3. 43  

book value:  3. 50   13. 02   27. 49  
price/book:  2. 72   4. 21   8. 80  
operating margins:  0. 00 % -380. 20 % -38. 44 %
EBITDA margins:  0. 00 % 13. 59 % 23. 24 %
profit margins:  0. 00 % 10. 94 % 14. 00 %
gross margins:  0. 00 % 36. 11 % 55. 16 %

1-yr max volatility:  19. 24 % --- ---
1-yr mean volatility:  3. 71 % 1. 50 % 1. 08 %

1-yr EPS:  -0. 63   2. 12   4. 26  
forward EPS:  -117. 20   3. 47   7. 14  
P/E:  -15. 02   2. 15   33. 17  
forward P/E:  -0. 08   -4. 03   17. 60  
PE/G:  5. 67   0. 54   0. 34  
growth:  -2. 65 % 263. 03 % 78. 34 %
earnings high:  -16. -16   0. 91   1. 70  
earnings avg:  -20. 25   0. 71   1. 58  
earnings low:  -23. -23   0. 48   1. 46  
revenue high:  -0. 00   2. 64 B 11. 26 B
revenue avg:  -0. 00   2. 58 B 11. 09 B
revenue low:  -0. 00   2. 54 B 10. 90 B
return on assets:  -16. 54 % -2. 31 % 5. 31 %
return on equity:  -15. 60 % -82. 48 % 135. 30 %

beta (1yr vs S&P500):  0. 68   1. 26   0. 91  
sharpe (1yr):  -0. 77   0. 07   0. 77  

held % insiders:  15. 36 % 6. 08 % 3. 31 %
held % institutions:  34. 62 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : NCNA
.    111.259 =       111.259 :: --> INITIAL WEIGHT <--
.    - 0.634 =       110.625 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.312 =       255.709 :: P/E factor
.    x 0.872 =       223.014 :: PE/G factor
.    x 1.527 =       340.529 :: beta factor
.    x 0.918 =       312.556 :: sharpe factor
.    x 2.555 =       798.666 :: current ratio factor
.    x 1.037 =       827.862 :: quick ratio factor
.    x 1.008 =        834.37 :: short ratio factor
.    x 1.024 =        854.07 :: price-to-book factor
.    x 1.006 =       859.192 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =      1816.317 :: sector+industry 1-year gains factor
.    x 1.033 =      1876.979 :: industry 12-weeks return factor
.    x 1.305 =      2449.971 :: industry 2-weeks return factor
.    x 0.865 =      2118.006 :: company one-year gains+dividend factor
.    x 0.967 =      2049.106 :: company 13 weeks' performance factor
.    / 2.083 =       983.896 :: overall "drift" factor
.    x 0.824 =       811.057 :: largest single-day jump factor
.    x 0.131 =       105.882 :: low price factor
.    x 1.389 =       147.019 :: notable returns + performance factor
.    x 3.365 =       494.771 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.     x 0.22 =       108.603 :: forward EPS factor
.    x 0.716 =        77.802 :: forward P/E factor
.    x 1.182 =        91.996 :: industry recommendation factor
.    x 1.008 =          92.7 :: factor historical industry gain for week 28
.    x 2.605 =       241.505 :: target low factor
.    x 1.442 =       348.224 :: target mean factor
.    x 1.058 =       368.514 :: target high factor
.   x 11.745 =      4328.274 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         8.111 :: reduced for readability
.     + 4.96 =        13.071 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     13.071 :: FINAL WEIGHT for NASDAQ:NCNA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org